alnylam targets “undruggable” diseases
Published 4 years ago • 133 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
3:26
first approved treatment using rnai – alnylam pharmaceuticals’ and bio chair john maraganore
-
2:56
rnai therapeutics - how this new class of medicines works
-
0:55
what is an rnai therapeutic?
-
4:10
alnylam's john maraganore discusses the bio fda survey initiative
-
1:02
how do rnai therapeutics treat disease?
-
2:19
get to know alnylam - the leader in rnai therapeutics
-
2:20
the futurists - developing a new class of medicines
-
0:57
how can unwanted proteins cause or contribute to disease?
-
14:25
nova sciencenow : 8 - rnai
-
1:05:12
founder stories: joshua boger, founder and ceo of vertex pharmaceuticals
-
59:30
founder stories: john maraganore, ceo of alnylam pioneering rnai therapeutics
-
2:32
what is rnai and how do rnai-based medicines work?
-
2:29
alnylam overview
-
2:53
from possibility to patients: the scientific odyssey - the dark ages
-
1:05
alnylam pharma and the science of rnai
-
2:20
the pioneers - developing a new class of medicines
-
2:43
from possibility to patients: the scientific odyssey - the rnai boom
-
2:17
the heroes - developing a new class of medicines
-
2:14
the believers - developing a new class of medicines